New Ovarian Cancer Treatment Advances: What You Should Know

What does the future of ovarian cancer treatment look like? In this episode of Teal Talk–An Ovarian Cancer Podcast, leading gynecologic oncology experts Dr. Sarah Taylor and Dr. Debra Richardson break down some of the most important advances happening in ovarian cancer research today. From biomarker testing and precision medicine to emerging therapies and clinical trials, this conversation explores how treatment is becoming more personalized than ever before. Experts discuss the latest developments shaping ovarian cancer care, including explaining complex topics like genetic testing, ctDNA, antibody-drug conjugates, and new treatment options in a way that is practical and meaningful for patients, caregivers, and advocates. This episode offers valuable insights into where ovarian cancer treatment is headed and what questions to ask your healthcare team. 00:00 Welcome to Teal Talk 00:40 What’s Changing Now 02:26 Testing and Biomarkers 03:39 Precision Medicine Explained 05:45 ctDNA Liquid Biopsies 08:06 Questions to Ask Doctors 10:15 Platinum Resistant Options 14:25 Newly Approved Regimens 15:55 Antibody Drug Conjugates 21:05 Low Grade Serous Updates 23:44 Germline Genetics Matters 25:37 Key Takeaways and Closing ​ 💬 Like, comment, and subscribe for more vital discussions about ovarian cancer. 📋 Survey Link: https://bit.ly/tealtalksurvey 👉 Learn more: https://ovarian.org Disclaimer: This podcast is for informational purposes only and does not replace medical advice, diagnosis, or treatment. Always talk to a qualified healthcare provider if you have questions about your health. The podcast is created independently by the National Ovarian Cancer Coalition and is not influenced by sponsors or outside groups. #TealTalkPodcast #OvarianCancer #KnowOvarian #TealTogether #PrecisionMedicine #BiomarkerTesting #OvarianCancerResearch #ClinicalTrials #TargetedTherapy #GynecologicOncology